• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在胸部X光片大规模筛查项目中检测到的肺癌体积倍增时间:与CT筛查的比较。

Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.

作者信息

Kanashiki Maki, Tomizawa Takuji, Yamaguchi Iwao, Kurishima Koichi, Hizawa Nobuyuki, Ishikawa Hiroichi, Kagohashi Katsunori, Satoh Hiroaki

机构信息

Ibaraki Health Service Association, Tsukuba, Japan.

出版信息

Oncol Lett. 2012 Sep;4(3):513-516. doi: 10.3892/ol.2012.780. Epub 2012 Jun 28.

DOI:10.3892/ol.2012.780
PMID:22970048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3439160/
Abstract

The aim of this study was to evaluate the volume doubling time (VDT) of lung cancer detected in our annual chest radiograph screening program and to compare it with those previously reported for computed tomography (CT) screening. In total, 209 patients who had a measurable tumor shadow and a history of participating in our chest radiograph mass screening program between 2006 and 2009 were included in this study. Indirect roentgenograms for patients with lung cancer were converted into digital images, and the section showing the tumor was enlarged on the monitor to a size of 0.01 mm. The mean VDT for all the patients was 158 days. Only 3.8% of the patients had a VDT of more than 400 days. In 140 patients with adenocarcinoma, the mean VDT was 177 days, and 5.0% of these patients had a VDT of more than 400 days. In the 44 patients with squamous cell carcinoma, the mean VDT was 133 days, and only 2.3% of these patients had a VDT of more than 400 days. These results were different from those previously reported for CT screening. In several reports on CT screening, more than 20% of the lung cancers had VDTs of more than 400 days. Since it is common knowledge that there are 'indolent' lung cancers with a VDT of more than 400 days, screening by annual chest radiography with rare overdiagnosis may need to be reconsidered.

摘要

本研究的目的是评估在我们的年度胸部X线筛查项目中检测到的肺癌的体积倍增时间(VDT),并将其与先前报道的计算机断层扫描(CT)筛查结果进行比较。本研究共纳入了209例在2006年至2009年间有可测量肿瘤阴影且有参与我们胸部X线大规模筛查项目病史的患者。将肺癌患者的间接X线片转换为数字图像,并在显示器上放大显示肿瘤的切片至0.01mm大小。所有患者的平均VDT为158天。只有3.8%的患者VDT超过400天。在140例腺癌患者中,平均VDT为177天,其中5.0%的患者VDT超过400天。在44例鳞状细胞癌患者中,平均VDT为133天,其中只有2.3%的患者VDT超过400天。这些结果与先前报道的CT筛查结果不同。在几份关于CT筛查的报告中,超过20%的肺癌VDT超过400天。由于众所周知存在VDT超过400天的“惰性”肺癌,因此可能需要重新考虑每年进行胸部X线筛查且很少过度诊断的情况。

相似文献

1
Volume doubling time of lung cancers detected in a chest radiograph mass screening program: Comparison with CT screening.在胸部X光片大规模筛查项目中检测到的肺癌体积倍增时间:与CT筛查的比较。
Oncol Lett. 2012 Sep;4(3):513-516. doi: 10.3892/ol.2012.780. Epub 2012 Jun 28.
2
Lung cancers diagnosed at annual CT screening: volume doubling times.年度 CT 筛查诊断出的肺癌:倍增时间。
Radiology. 2012 May;263(2):578-83. doi: 10.1148/radiol.12102489. Epub 2012 Mar 27.
3
Lung cancer screening intervals based on cancer risk.基于癌症风险的肺癌筛查间隔。
Lung Cancer. 2020 Nov;149:113-119. doi: 10.1016/j.lungcan.2020.09.013. Epub 2020 Sep 23.
4
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.五年肺癌筛查经验:61例肺癌的CT表现、生长速度、位置及组织学特征
Radiology. 2007 Feb;242(2):555-62. doi: 10.1148/radiol.2422052090.
5
Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.肺腺癌倍增时间:与主要组织学亚型和预后的相关性。
Radiology. 2020 Jun;295(3):703-712. doi: 10.1148/radiol.2020191835. Epub 2020 Mar 31.
6
Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.肺腺癌的 WHO 组织学分型与体积倍增时间和质量倍增时间的关系。
Korean J Radiol. 2021 Mar;22(3):464-475. doi: 10.3348/kjr.2020.0592. Epub 2020 Oct 30.
7
Lung cancer volume doubling time by computed tomography: A systematic review and meta-analysis.肺癌 CT 倍增时间:系统评价和荟萃分析。
Eur J Cancer. 2024 Nov;212:114339. doi: 10.1016/j.ejca.2024.114339. Epub 2024 Sep 26.
8
Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.用低剂量计算机断层扫描筛查肺癌的过度诊断估计:一项队列研究。
Ann Intern Med. 2012 Dec 4;157(11):776-84. doi: 10.7326/0003-4819-157-11-201212040-00005.
9
PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times.原发性肺癌的 PET 标准化摄取值与肿瘤倍增时间的比较。
Clin Imaging. 2021 May;73:146-150. doi: 10.1016/j.clinimag.2020.11.048. Epub 2020 Dec 3.
10
Prediction of Surgical Outcome by Tumor Volume Doubling Time via Stereo Imaging Software in Early Non-Small Cell Lung Cancer.通过立体成像软件利用肿瘤体积倍增时间预测早期非小细胞肺癌的手术结果
Cancers (Basel). 2023 Aug 3;15(15):3952. doi: 10.3390/cancers15153952.

引用本文的文献

1
Lung cancer associated autoantibody responses are detectable years before clinical presentation.肺癌相关的自身抗体反应在临床表现出现前数年就可检测到。
PLoS One. 2025 Mar 11;20(3):e0315220. doi: 10.1371/journal.pone.0315220. eCollection 2025.
2
Towards ultra-low-dose CT for detecting pulmonary nodules using DenseNet.迈向使用密集连接网络进行超低剂量CT检测肺结节的研究
Phys Eng Sci Med. 2025 Mar;48(1):379-389. doi: 10.1007/s13246-025-01520-6. Epub 2025 Feb 10.
3
Biomarker trajectory for earlier detection of lung cancer.生物标志物轨迹用于早期肺癌检测。
EBioMedicine. 2024 Oct;108:105377. doi: 10.1016/j.ebiom.2024.105377. Epub 2024 Sep 30.
4
Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach.从患者来源的异种移植(PDX)模型预测未经治疗的患者的肿瘤倍增时间和无进展生存期:一种基于转化模型的方法。
AAPS J. 2024 Aug 8;26(5):92. doi: 10.1208/s12248-024-00960-4.
5
Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients.循环肿瘤细胞:推动小细胞肺癌患者的个性化治疗
Mol Oncol. 2024 Jul 2. doi: 10.1002/1878-0261.13696.
6
Lung nodule malignancy classification with associated pulmonary fibrosis using 3D attention-gated convolutional network with CT scans.使用 CT 扫描的 3D 注意力门控卷积网络进行肺结节良恶性分类及相关肺纤维化分析。
J Transl Med. 2024 Jan 13;22(1):51. doi: 10.1186/s12967-023-04798-w.
7
Rapidly Growing Chest Wall Lipoma: Case Report and Calculating Volume Doubling Time.快速生长的胸壁脂肪瘤:病例报告及体积倍增时间计算
Maedica (Bucur). 2023 Sep;18(3):523-527. doi: 10.26574/maedica.2023.18.3.523.
8
Solitary lung adenocarcinoma: follow-up CT, pathological-molecular characteristics, and surgical prognosis for different morphological classifications.孤立性肺腺癌:不同形态学分类的随访CT、病理分子特征及手术预后
Insights Imaging. 2023 Nov 27;14(1):209. doi: 10.1186/s13244-023-01563-x.
9
A narrative review of the clinical approach to subsolid pulmonary nodules.亚实性肺结节临床处理方法的叙述性综述
Ann Transl Med. 2023 Mar 15;11(5):217. doi: 10.21037/atm-22-5246. Epub 2023 Mar 10.
10
Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers.倍增时间和放射组学特征可预测筛查发现的肺癌的肿瘤行为。
Cancer Biomark. 2022;33(4):489-501. doi: 10.3233/CBM-210194.

本文引用的文献

1
Screen-detected lung cancer: a retrospective analysis of CT appearance.筛查发现的肺癌:CT 表现的回顾性分析。
Acad Radiol. 2011 Oct;18(10):1270-6. doi: 10.1016/j.acra.2011.06.005. Epub 2011 Aug 3.
2
Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry.多排螺旋 CT 检测磨玻璃密度肺结节倍增时间:计算机辅助三维容积法评估。
Acad Radiol. 2011 Jan;18(1):63-9. doi: 10.1016/j.acra.2010.08.022.
3
HRCT features of small peripheral lung carcinomas detected in a low-dose CT screening program.低剂量 CT 筛查项目中检出的小周边型肺癌的 HRCT 特征。
Acad Radiol. 2010 Jan;17(1):75-83. doi: 10.1016/j.acra.2009.08.003. Epub 2009 Oct 30.
4
Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma.利用三维体积软件测定肺癌倍增时间:鳞癌与腺癌的比较。
Lung Cancer. 2009 Nov;66(2):211-7. doi: 10.1016/j.lungcan.2009.01.018. Epub 2009 Feb 28.
5
Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.在NELSON研究中,基线CT筛查时检测到的光滑或附着性实性不确定结节:1年随访期间的癌症风险
Radiology. 2009 Jan;250(1):264-72. doi: 10.1148/radiol.2493070847. Epub 2008 Nov 4.
6
Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers.五年肺癌筛查经验:61例肺癌的CT表现、生长速度、位置及组织学特征
Radiology. 2007 Feb;242(2):555-62. doi: 10.1148/radiol.2422052090.
7
Nodule management protocol of the NELSON randomised lung cancer screening trial.NELSON随机肺癌筛查试验的结节管理方案
Lung Cancer. 2006 Nov;54(2):177-84. doi: 10.1016/j.lungcan.2006.08.006. Epub 2006 Sep 20.
8
A biomathematical approach to clinical tumor growth.一种临床肿瘤生长的生物数学方法。
Cancer. 1961 Nov-Dec;14:1272-94. doi: 10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h.
9
Overdiagnosis in chest radiographic screening for lung carcinoma: frequency.肺癌胸部X线筛查中的过度诊断:发生率
Cancer. 2003 Mar 1;97(5):1271-5. doi: 10.1002/cncr.11185.
10
Growth rate of small lung cancers detected on mass CT screening.在大规模CT筛查中发现的小肺癌的生长速率。
Br J Radiol. 2000 Dec;73(876):1252-9. doi: 10.1259/bjr.73.876.11205667.